Rafael Fonseca, M.D., is a clinical investigator for the Damon Runyon Cancer Research Fund. Dr. Fonseca earned his medical degree at Universidad Anahuac, Mexico. He completed a residency in internal medicine at the University of Miami, Florida, and a fellowship in Hematology and Oncology at Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota.
Dr. Fonseca's practice focuses on diagnosing and treating plasma cell disorders. He also leads the multiple myeloma team in its effort to develop a better understanding of the disease and its impact on patients. In his laboratory, Dr. Fonseca has led his team of researchers in concentrating on the genetic nature of the clonal cells of plasma cell disorders. He also has expertise in myeloma bone disease, prognostic markers, and development of new therapies for the disease.
Dr. Fonseca's research has been funded by the National Cancer Institute (R01, P01, SPORE), the Leukemia and Lymphoma Society, the Multiple Myeloma Research Fund, and the Damon Runyon Cancer Research Fund. He has given many national and international presentations as a visiting professor and has authored numerous articles (over 200), book chapters, editorials, abstracts, and letters.